Unicycive Therapeutics Inc. Gains 23.7%
Fri, Jun 28, 2024 at 07:16 PM
Unicycive Therapeutics Inc. (UNCY:NASDAQ) jumped higher at $0.5, representing a gain of 23.7%. On Fri, Jun 28, 2024, UNCY:NASDAQ hit a New 2-Week Intraday Low of $0.4. The stock got featured on our News Catalysts scanner on Tue, Jun 25, 2024 at 08:57 AM in the 'BIOTECH' category. From Fri, Jun 14, 2024, the stock recorded 33.33% Up Days and 10.00% Green Days
About Unicycive Therapeutics Inc. (UNCY:NASDAQ)
Unicycive Therapeutics Inc is a biotechnology company dedicated towards developing treatments for certain medical conditions. It is focusing on kidney diseases.
Top 10 Gainers:
- Innovative Eyewear Inc. (LUCY:NASDAQ), 50%
- Nano Nuclear Energy Inc. (NNE:NASDAQ), 44.51%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- The Marygold Companies Inc. (MGLD:NYSEMKT), 30.43%
- Envirotech Vehicles Inc. (EVTV:NASDAQ), 28.19%
- CalciMedica Inc Com (New) (CALC:NASDAQ), 25.71%
- Solidion Technology Inc. (STI:NASDAQ), 25%
- CBL International Limited (BANL:NASDAQ), 24.97%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 23.7%